Antibodies are proteins produced by the immune system in response to the presence of antigens (foreign substances). They are specialised in recognising and binding to antigens, helping the immune system recognise and eliminate pathogens like viruses and bacteria.
Antibody therapy, also known as immunotherapy or monoclonal antibody therapy, is a medical treatment that involves the use of antibodies as drugs to treat diseases. It is a targeted approach used in the treatment of various conditions, including cancer, autoimmune diseases, infectious diseases etc.
An antigen is a molecule or molecular structure that the immune system recognises as foreign or non-self. Antigens can be found on the surface of pathogens, cells, or foreign substances and trigger an immune response. They are essential for the body's defence against infections.
Biologics are large and complex molecules derived from living organisms, such as proteins or nucleic acids (e.g., DNA, RNA). They are often used as drugs to treat a variety of diseases, including cancer, autoimmune disorders, and infectious diseases. Examples of biologics include monoclonal antibodies, vaccines, and gene therapies.
Developability refers to the assessment of a drug candidate's suitability in the drug development process. It involves evaluating various aspects of a compound, such as its chemical properties, stability, safety profile, solubility, manufacturability, to determine its potential to become a successful drug.
Immunisation is the process of inducing immunity in an animal to a specific disease. In the antibody development process, it involves exposing a laboratory animal (such as a mouse or rabbit) to a specific antigen to stimulate the production of antibodies against that antigen.
Immunogenicity is the property of a drug to induce an immune response in the body. In drug development, it is important to assess immunogenicity to ensure that the patient’s immune system's response to the drug does not lead to adverse effects.
Small molecules are low molecular weight organic compounds which can be synthesised chemically. They are used as drugs to target specific proteins or pathways involved in diseases.
TechBio represents the intersection of technology and biology. The term places a strong emphasis on the transformative role of advanced technology in shaping the future of biological research and innovation. TechBio signifies a new era of companies that are integrating artificial intelligence, data analytics, and automation in biological sciences.
A vaccine is a biological preparation that stimulates the immune system to generate an immune response against a specific pathogen, like a virus or bacterium. Vaccines are used to prevent infectious diseases by exposing the immune system to an inactivated or weakened form of the causative agent or its component.